Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...
Richard Francis, Teva Pharmaceuticals CEO, joins CNBC's 'Money Movers' to discuss the company's most recent quarter, what's ...
Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...
Medical professionals in the U.S. and worldwide came to understand the global nature of medical supply chains during the COVID-19 pandemic. Shortages of personal protective equipment (PPE), SARS-CoV-2 ...
The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...
Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...
Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to beat earnings when it reports second-quarter 2025 results on Aug. 5 ...
Across the recent three months, 10 analysts have shared their insights on Ionis Pharmaceuticals (NASDAQ:IONS), expressing a variety of opinions spanning from bullish to bearish. In the table below, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback